ARWR - ARROWHEAD PHARMACEUTICALS, INC.
IEX Last Trade
19.61
0.060 0.306%
Share volume: 25,065
Last Updated: Thu 26 Dec 2024 08:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$19.55
0.06
0.31%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-08-04 | 2022-11-28 | 2023-02-06 | 2023-05-02 | 2023-08-07 | 2023-11-29 | 2024-02-06 | 2024-05-09 | |
| Total revenue | 32.412 M | 31.575 M | 62.546 M | 146.267 M | 15.825 M | 16.097 M | 3.551 M | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 32.412 M | 31.575 M | 62.546 M | 146.267 M | 15.825 M | 16.097 M | 3.551 M | 0.000 | |
| -2.58% | 98.09% | 133.86% | -89.18% | 1.72% | -77.94% | -100.00% | |||
| Operating expenses | 105.321 M | 115.405 M | 104.680 M | 98.102 M | 118.528 M | 124.427 M | 140.096 M | 126.191 M | |
| Selling general and admin | 33.141 M | 32.028 M | 20.985 M | 23.221 M | 23.771 M | 24.572 M | 23.605 M | 25.069 M | |
| Research and development | 72.180 M | 83.377 M | 83.695 M | 74.881 M | 94.757 M | 99.855 M | 116.491 M | 101.122 M | |
| Total expenses | 105.321 M | 115.405 M | 104.680 M | 98.102 M | 118.528 M | 124.427 M | 140.096 M | 126.191 M | |
| 9.57% | -9.29% | -6.28% | 20.82% | 4.98% | 12.59% | -9.93% | |||
| Operating income | -72.909 M | -83.830 M | -42.134 M | 48.165 M | -102.703 M | -108.330 M | -136.545 M | -126.191 M | |
| Ebit | -72.909 M | -83.830 M | -42.134 M | 48.165 M | -102.703 M | -108.330 M | -136.545 M | -126.191 M | |
| Pretax income | -72.046 M | -82.157 M | -41.794 M | 47.676 M | -103.383 M | -108.990 M | -138.689 M | -126.996 M | |
| 14.03% | -49.13% | -214.07% | -316.84% | 5.42% | 27.25% | -8.43% | |||
| Income tax | 0.000 | 3.785 M | 17.000 K | 0.000 | 742.000 K | 2.025 M | -3.313 M | 0.000 | |
| Net income basic | -72.046 M | -85.511 M | -41.325 M | 48.675 M | -102.946 M | -109.679 M | -132.864 M | -125.300 M | |
| -18.69% | 51.67% | 217.79% | -311.50% | -6.54% | -21.14% | 5.69% | |||
| Net income | -72.046 M | -85.511 M | -41.325 M | 48.675 M | -102.946 M | -109.679 M | -132.864 M | -125.300 M | |
| -18.69% | 51.67% | 217.79% | -311.50% | -6.54% | -21.14% | 5.69% |